Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 15Lung Neoplasms 7Nasopharyngeal Carcinoma 6Colorectal Neoplasms 4Breast Neoplasms 3Uterine Cervical Neoplasms 2Melanoma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Esophageal Neoplasms 2Stomach Neoplasms 1Sarcoma 1Recurrence 1Radiation Injuries 1Quality of Life 1Osteosarcoma 1Non-squamous Non-small Cell Lung Cancer 1Neuroblastoma 1Nasopharyngeal Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Brain Neoplasms 1Advanced Pancreatic Cancer 1Advanced Colorectal Cancer 1Adenocarcinoma of Lung 1

Interventions

Cisplatin 32Paclitaxel 29Radiotherapy 21Fluorouracil 20Radiation 12camrelizumab 11Oxaliplatin 11Docetaxel 11Carboplatin 10Capecitabine 9Esophagectomy 8Surgical Procedures, Operative 7Radiotherapy, Intensity-Modulated 6Leucovorin 6Endoscopic Mucosal Resection 6Drug Therapy 6apatinib 5Neoadjuvant Therapy 5Chemoradiotherapy 5nedaplatin 4S 1 (combination) 4Preoperative Exercise 4Irinotecan 4Endoscopy 4Cetuximab 4Albumin-Bound Paclitaxel 4pembrolizumab 3TP protocol 3Radiotherapy, Adjuvant 3Epirubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Esophageal Neoplasms × endostar protein × Clear all
NCT03649945 2018-08-28

Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer

First Affiliated Hospital of Guangxi Medical University

Phase 2 Unknown
186 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01368419 2013-04-24

Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 2 Unknown
40 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡